Oxidative activation of proguanil and dapsone acetylation in Thai soldiers
- PMID: 8148220
- PMCID: PMC1364712
- DOI: 10.1111/j.1365-2125.1994.tb04241.x
Oxidative activation of proguanil and dapsone acetylation in Thai soldiers
Abstract
The prevalence of putative poor metaboliser (PM) phenotypes of proguanil oxidation in Caucasian populations is 3-10%. The PM frequency in Oriental populations is unknown. In this study the plasma metabolic ratios of proguanil and dapsone to their principal metabolites cycloguanil and monoacetyldapsone were determined in Thai soldiers receiving antifolate drug combinations for malaria prophylaxis. The distribution ratio of proguanil to cycloguanil (PROG/CYC) was highly skewed with no evidence of bimodality. Assuming subjects with a PROG/CYC ratio greater than 10 are PMs from studies in Caucasians, the incidence of PMs in the soldiers would be 18% (30 of 170). The mean PROG/CYC ratio for PMs in the Thai soldiers was 31.2 +/- 28.9 (n = 30) compared with 25.5 +/- 2.5 (n = 3) in a study of Caucasians. The corresponding values for putative EMs were 5.4 +/- 2.1 (n = 140) and 2.4 +/- 0.2 (n = 134). Similar to other Oriental populations, Thais were found to be predominantly (76%, 173 of 228) rapid acetylators of dapsone.
Similar articles
-
Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates.Acta Trop. 1997 Sep 10;66(3):127-35. doi: 10.1016/s0001-706x(97)00044-2. Acta Trop. 1997. PMID: 9210963
-
Proguanil polymorphism does not affect the antimalarial activity of proguanil combined with atovaquone in vitro.Trans R Soc Trop Med Hyg. 1996 Jul-Aug;90(4):418-21. doi: 10.1016/s0035-9203(96)90531-3. Trans R Soc Trop Med Hyg. 1996. PMID: 8882194
-
Malaria chemoprophylaxis using proguanil/dapsone combinations on the Thai-Cambodian border.Am J Trop Med Hyg. 1992 Jun;46(6):643-8. doi: 10.4269/ajtmh.1992.46.643. Am J Trop Med Hyg. 1992. PMID: 1621888 Clinical Trial.
-
Malaria prophylaxis during military operations in Thailand.Mil Med. 1989 Oct;154(10):500-2. Mil Med. 1989. PMID: 2515474 Review.
-
Malaria. Chemoprophylaxis and chemotherapy.Br Med J. 1971 Apr 10;2(5753):95-8. doi: 10.1136/bmj.2.5753.95. Br Med J. 1971. PMID: 4927912 Free PMC article. Review. No abstract available.
Cited by
-
Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.Br J Clin Pharmacol. 1999 Aug;48(2):158-67. doi: 10.1046/j.1365-2125.1999.00005.x. Br J Clin Pharmacol. 1999. PMID: 10417492 Free PMC article.
-
Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil.Eur J Clin Pharmacol. 2003 Oct;59(7):553-7. doi: 10.1007/s00228-003-0651-x. Epub 2003 Aug 30. Eur J Clin Pharmacol. 2003. PMID: 12955370 Clinical Trial.
-
Phenotyping and genotyping of CYP2C19 using comparative metabolism of proguanil in sickle-cell disease patients and healthy controls in Nigeria.Pharmacol Res Perspect. 2016 Aug 22;4(5):e00252. doi: 10.1002/prp2.252. eCollection 2016 Oct. Pharmacol Res Perspect. 2016. PMID: 27713823 Free PMC article.
-
Evidence for the polymorphic oxidation of debrisoquine and proguanil in a Khmer (Cambodian) population.Br J Clin Pharmacol. 1995 Aug;40(2):166-9. doi: 10.1111/j.1365-2125.1995.tb05772.x. Br J Clin Pharmacol. 1995. PMID: 8562301 Free PMC article.
-
The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.Eur J Clin Pharmacol. 2003 Oct;59(7):545-52. doi: 10.1007/s00228-003-0652-9. Epub 2003 Aug 30. Eur J Clin Pharmacol. 2003. PMID: 12955371 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical